Featured Article

Researchers at Case Western Reserve University say that a class of diabetes drugs used to treat type 2 diabetes may reduce the risk of the development of colorectal cancer (CRC).

Precision Oncology Today

Magazine

The Digital Pathway to Widespread Precision Medicine

Digital health tools and technologies were thrust into the spotlight during the pandemic and were able to help many people get much needed medical...
Artificial Intelligence

Generative AI and Precision Medicine–The Future Is Not What It Used to Be

Generative AI is a new and rapidly emerging form of artificial intelligence that has the potential to revolutionize precision medicine by improving diagnosis, treatment, and drug discovery.
Person getting blood work

Pushing the Performance of Liquid Biopsies for Cancer with Nanotechnology

Nanotechnology opens the door to a range of unique methods for sensing cancer biomarkers in body fluids, thanks to the unusual properties and capabilities of nanoscale systems. Going small promises big gains in diagnosing and tracking a wide range of tumors.

Trending on Inside Precision Medicine

Seattle Hub for Synthetic Biology Launched with Jay Shendure at the Helm

The newly launched Seattle Hub for Synthetic Biology will build new technologies to record the history of cells over time.
A 2D vessel network (82 mm by 68 mm by 1 mm) was printed on a 3.41-MHz FUS using a PEGDA-based sono-ink.

3D Printing Could Build Tissues within Body

A 3D printing technique that uses sound waves could one day be used to build and repair tissues from within the body, paving the way towards minimally invasive medicine.
Colorectal cancer, intestinal carcinoma, colon cancer, bowel neoplasia, 3D illustration

Class of Diabetes Drugs May Prevent Development of Colorectal Cancer

Researchers at Case Western Reserve University say that a class of diabetes drugs used to treat type 2 diabetes may reduce the risk of the development of colorectal cancer (CRC).

Daily News

Related Content

Inside Precision Medicine